We are monitoring the impact of COVID-19 on Europe ECMO Machine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4799
Share on
Share on

Europe ECMO Machine Market Research Report – By Modality, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4799
Pages: 145

Europe Extracorporeal Membrane Oxygenation Machine Market Size & Growth (2021 to 2026):

According to the report, the Europe ECMO Machine Market size is forecasted to grow USD 87 Million by 2026 from USD 70.18 Million in 2021, registering a CAGR of 4.39% between 2021 to 2026. 

Extracorporeal membrane oxygenation machines are medical devices that provide extracorporeal life support to patients with cardiac and respiratory problems who cannot gas exchange or carry out adequate perfusion to sustain their lives. Because their organs cannot work as they should, this procedure allows patients to stay alive for longer.

The market is predicted to grow due to favorable reimbursement conditions, increased lung cancer incidence, and the availability of a significant number of ECMO centers. In addition, the market is expected to expand due to the rising number of people suffering from respiratory disorders such as pulmonary hypertension, respiratory failure, respiratory distress syndrome, meconium aspiration syndrome, and cardiovascular illnesses.

According to Eurostat data, around 61 percent of women and 45 percent of men in Estonia died in 2014 due to cardiovascular disorders. According to the Luce Report on Lung Cancer 2016, almost 312,000 persons in Europe have been diagnosed with lung cancer. According to the European Cardiovascular Disorders Statistics, 85 million persons and above in Europe suffered from cardiovascular diseases in 2015.

The stringent medical device approval regulations are limiting the growth. In addition, the ECMO equipment market faces obstacles such as a scarcity of experienced specialists and expensive therapy costs. For efficient market penetration, we must overcome a few hurdles. There are minimal difficulties associated with these devices due to a lack of qualified labor. However, the usage of these machines increases the risk of respiratory infections, which is one of the major concerns of the market. 

This research report on the Europe Extracorporeal Membrane Oxygenation Machine Market has been segmented and sub-segmented into the following categories

By Modality:

  • Veno-Arterial (VA)
  • Veno-Venous (VV)
  • Arterio-Venous (AV)

By Application:

  • Respiratory
  • Cardiac
  • Extracorporeal Cardiopulmonary Resuscitation (ECPR)

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the Europe has the world's second-largest market share. The Extracorporeal membrane oxygenation (ECMO) machine market growth is expected to be driven by an increase in the frequency of cardiovascular disorders, increasing healthcare expenditure, and favorable reimbursement policies. United Kingdom, Poland, Germany, Belgium, Italy, France, Russia, and the rest of Europe contribute to European regional market growth. 

The UK ECMO Market dominates the global market in the region. The presence of well-established healthcare infrastructure, an increase in chronic diseases such as cardiac and respiratory diseases resulting from lifestyle changes and diet habits, and key players' participation with various tactics contribute to the regional market growth. For example, coronary heart disease claimed the lives of 66,341 people in the United Kingdom. ECMO can be used to control the death rate. As a result, there is room for market expansion in the United Kingdom.

Because of the expanding aging population, the UK is following Germany in leading the industry; important players are developing new products and collaborating strategically to establish the market in this region. In addition, the European government has taken several steps to boost the demand for extracorporeal membrane oxygenation machines.

Increase in the frequency of cardiovascular disorders and a large number of ECMO centers. According to the most available WHO data, coronary heart disease fatalities accounted for 16.54 percent of all deaths in Belgium in 2018. In addition, according to the Belgian Society for Extracorporeal Technology, the Coronavirus has boosted the use of venovenous ECMO. It is due to the virus's propensity for affecting lung function.

KEY MARKET PLAYERS

Prominent Companies dominating the Europe Extracorporeal Membrane Oxygenation Machine Market Profiled in the Report are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc., and EUROSETS S.r.l.

1.Introduction               

                1.1 Market Definition 

                1.2 Study Deliverables 

                1.3 Base Currency, Base Year and Forecast Periods       

                1.4 General Study Assumptions

2. Research Methodology                        

                2.1 Introduction            

                2.2 Research Phases   

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design      

                2.4 Study Timeline       

3. Overview                    

                3.1 Executive Summary

                3.2 Key Inferences      

                3.3 Epidemiology           

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                 

                4.1 Market Drivers       

                4.2 Market Restraints 

                4.3 Key Challenges      

                4.4 Current Opportunities in the Market           

5. Market Segmentation                           

                5.1 Modality   

                                5.1.1 Introduction                                                           

                                5.1.2 Venovenous ECMO                                                             

                                5.1.3 Venoarterial ECMO                                                             

                                5.1.4 Arteriovenous ECMO                                                         

                                5.1.5  Y-o-Y Growth Analysis, By Modality                                                            

                                5.1.6  Market Attractiveness Analysis, By Modality                                                          

                                5.1.7  Market Share Analysis, By Modality                                                            

                5.2 Application

                                5.2.1 Introduction                                                           

                                5.2.2 Respiratory Applications                                                   

                                                5.2.2.1 Neonates                                             

                                                5.2.2.2 Pediatrics                                             

                                                5.2.2.3 Adults                                    

                                5.2.3 Cardiac Applications                                                            

                                                5.2.3.1 Neonates                                             

                                                5.2.3.2 Pediatrics                                             

                                                5.2.3.3 Adults                                    

                                5.2.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)                                                        

                                                5.2.4.1 Neonates                                             

                                                5.2.4.2 Pediatrics                                             

                                                5.2.4.3 Adults                                    

                                5.2.5 Y-o-Y Growth Analysis, By Application                                                         

                                5.2.6 Market Attractiveness Analysis, By Application                                                       

                                5.2.7 Market Share Analysis, By Application                                                        

6. Geographical Analysis                           

                6.1 Introduction            

                                6.1.1 Regional Trends                                                    

                                6.1.2 Impact Analysis                                                     

                                6.1.3 Y-o-Y Growth Analysis                                                        

                                                6.1.3.1 By Geographical Area                                     

                                                6.1.3.2 By Modality                                         

                                                6.1.3.3 By Application                                    

                                6.1.4  Market Attractiveness Analysis                                                     

                                                6.1.4.1 By Geographical Area                                     

                                                6.1.4.2 By Application                                    

                                                6.1.4.3 By Type                                 

                                6.1.5  Market Share Analysis                                                      

                                                6.1.5.1 By Geographical Area                                     

                                                6.1.5.2 By Modality                                         

                                                6.1.5.3 By Application                                    

                6.2 U.K

                6.3 Spain          

                6.4 Germany  

                6.5 Italy            

                6.6 France       

               6.7 Rest of Europe

7.Strategic Analysis                     

                7.1 PESTLE analysis      

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis           

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8.Market Leaders' Analysis                      

                8.1 Getinge Group       

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Financial analysis                                                  

                                8.1.4 Recent Developments                                                       

                                8.1.5 SWOT analysis                                                       

                                8.1.6 Analyst View                                                          

                8.2 Medtronic plc         

                8.3 LivaNova PLC          

                8.4 XENIOS AG

                8.5 Terumo Corporation            

                8.6 MicroPort Scientific Corporation    

                8.7 NIPRO Corporation

                8.8 OriGen Biomedical Inc.       

                8.9 ALung Technologies Inc.    

                8.10 EUROSETS S.r.l.    

9.Competitive Landscape                         

                9.1 Market share analysis         

                9.2 Merger and Acquisition Analysis    

                9.3 Agreements, Collaborations, and Joint Ventures      

                9.4 New Product Launches      

10.Market Outlook and Investment Opportunities                       

Appendix                        

                a) List of Tables

                b) List of Figures           

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Modality and Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Europe Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensivePESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2021 to 2026 ( USD Million )
  2. Europe Veno-Arterial (VA) Market By Region, From 2021 to 2026 ( USD Million )
  3. Europe Veno-Venous (VV) Market By Region, From 2021 to 2026 ( USD Million )
  4. Europe Arterio-Venous (AV) Market By Region, From 2021 to 2026 ( USD Million )
  5. Europe Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2021 to 2026 ( USD Million )
  6. Europe Respiratory Market By Region, From 2021 to 2026 ( USD Million )
  7. Europe Cardiac Market By Region, From 2021 to 2026 ( USD Million )
  8. Europe Extracorporeal Cardiopulmonary Resuscitation (ECPR)) Market By Region, From 2021 to 2026 ( USD Million )
  9. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2021 to 2026 ( USD Million )
  10. U.K. Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2021 to 2026 ( USD Million )
  11. Germany Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2021 to 2026 ( USD Million )
  12. Germany Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2021 to 2026 ( USD Million )
  13. France Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2021 to 2026 ( USD Million )
  14. France Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2021 to 2026 ( USD Million )
  15. Italy Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2021 to 2026 ( USD Million )
  16. Italy Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2021 to 2026 ( USD Million )
  17. Spain Extracorporeal Membrane Oxygenation Machine  Market By Modality, From 2021 to 2026 ( USD Million )
  18. Spain Extracorporeal Membrane Oxygenation Machine  Market By Application, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample